Investment
Features
FeesSafety
Academy
More
Pluang+

US Solana ETFs see record $188M inflows, led by Bitwise's BSOL product

Market News
28 Sep 2026
CrowdFundInsider
View Source
Bullish
US Solana ETFs see record $188M inflows, led by Bitwise's BSOL product

US spot Solana exchange-traded funds (ETFs) attracted about $188 million in net new money last week, marking the largest weekly inflow since their launch in October 2025. Bitwise's BSOL product dominated, capturing roughly 68% of the total inflows, followed by Grayscale and Fidelity. This surge indicates fresh capital entering Solana ETFs, separate from trading volume, and comes amid broader crypto fund inflows including Bitcoin and Ether ETFs. The growing interest in Solana ETFs may signal increasing investor demand despite SOL's price remaining below its previous peak, while ongoing network upgrades aim to improve transaction speed.

The recent surge in US spot Solana ETFs saw $188 million inflows last week, led by Bitwise's BSOL capturing 68% of that total. For readers following the broader crypto market, here is Pluang's snapshot as of Sep 29, 2026 03:53 WIB: out of 50 major cryptocurrencies, only 10 rose while 39 fell. Notably, BAL (Balancer) gained 11.14% to Rp16.297, contrasting with COTI dropping 12.73% to Rp231 and UNI down 9.99% to Rp157.683, reflecting mixed investor sentiment across assets.

More News

Several high-volume stocks plunge sharply amid profit-taking despite positive updates.

Several high-volume stocks plunge sharply amid profit-taking despite positive updates.

Several high-volume stocks including ITG Inc, Adicet Bio, Jaguar Health, Ocular Therapeutix, and Greenland Mines experienced sharp declines despite recent positive company news. The drops, ranging from about 19% to over 32%, appear driven by profit-t...

Market News
Bearish
2 hours ago
Stocks jump on clinical trial updates, acquisition deals, and trading momentum.

Stocks jump on clinical trial updates, acquisition deals, and trading momentum.

Kodiak Sciences surged 178% following positive Phase III trial updates for a wet age-related macular degeneration treatment. Lifecore Biomedical rose 55% after agreeing to a $663.7 million acquisition by Webster Equity Partners. YD Bio gained 22%, li...

Market News
Bullish
2 hours ago
Lifecore Biomedical shares jump 55% on acquisition news, analyst downgrades to Hold.

Lifecore Biomedical shares jump 55% on acquisition news, analyst downgrades to Hold.

Lifecore Biomedical's stock surged 55.24% to $6.52 after announcing an acquisition by Webster Equity Partners offering $6.28 per share in cash plus potential Contingent Value Rights up to $9.67 per share. The deal values the company at up to $663.7 m...

Market News
Bullish
3 hours ago
Espey director sells shares amid stock valued 112% above fair value despite strong earnings.

Espey director sells shares amid stock valued 112% above fair value despite strong earnings.

A director of Espey Manufacturing and Electronics Corp sold 100 shares at $64.49 each, reducing his holdings to 20,550 shares. This insider sale happened after the company reported strong 2026 financial results, including net sales growth to $46.1 mi...

Market News
Neutral
3 hours ago
Vail Resorts beats Q4 revenue estimates, targets $106M in cost savings for profit boost

Vail Resorts beats Q4 revenue estimates, targets $106M in cost savings for profit boost

Vail Resorts reported Q4 earnings per share of -$5.34, slightly better than expected, with revenue of $278.1 million surpassing estimates. The company benefited from a 5.2% rise in mountain revenues, driven by strong pass sales in Australia and stabl...

Company Fundamentals
Bullish
3 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App